Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07143786 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Human Induced Neural Stem Cell-derived Exosomes for Treating Acute Ischemic Stroke

Study acronym: NSAIS
StatusNot Yet Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Xuanwu Hospital, Beijing
204 trials monitored
See 3 trials at risk
Stroke
3,531 trials monitored
See 153 trials at risk
A phase I/IIa clinical trial investigating the safety and preliminary efficacy of intravenous administration of human induced neural stem cell-derived exosomes for acute ischemic stroke
Trial Details
NCT Number NCT07143786
Lead Sponsor Xuanwu Hospital, Beijing
Collaborators: Wiseheart Co.Ltd
Conditions
(from sponsor)		 Ischemic Stroke, Acute
Related terms Ischemic Stroke
Enrollment 38 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov